RXD

Pharmacy/Treatment Dispense

HL7 Attribute Table - RXD - Pharmacy/Treatment Dispense
27
C.LenElementv2.3.1
1..4-NMR1-00334RXD-1Dispense Sub-ID Counter
2..250-CE_0292R1029200335RXD-2Dispense/Give CodeLength
3..26-TSR1-00336RXD-3Date/Time Dispensed
4..20-NMR1-00337RXD-4Actual Dispense Amount
5..250-CEC1-00338RXD-5Actual Dispense UnitsLength
6..250-CEO1-00339RXD-6Actual Dosage FormLength
7..20-STR1-00325RXD-7Prescription Number
8..20-NMC1-00326RXD-8Number of Refills Remaining
9..200-STO*-00340RXD-9Dispense Notes
10..200-XCNO*-00341RXD-10Dispensing Provider
11..1-IDO1016700322RXD-11Substitution Status
12..10-CQO1-00329RXD-12Total Daily Dose
13..200-LA2C1-01303RXD-13Dispense-To Location
14..1-IDO1013600307RXD-14Needs Human Review
15..250-CEO*-00330RXD-15Pharmacy/Treatment Supplier's Special Dispensing Instructions2
16..20-NMO1-01132RXD-16Actual Strength
17..250-CEO1-01133RXD-17Actual Strength UnitLength
18..20-STO*-01129RXD-18Substance Lot Number
19..26-TSO*-01130RXD-19Substance Expiration Date
20..250-CE_0227O*022701131RXD-20Substance Manufacturer NameLength
21..250-CEO*-01123RXD-21IndicationLength
22..20-NMO1-01220RXD-22Dispense Package Size
23..250-CEO1-01221RXD-23Dispense Package Size UnitLength
24..2-IDO1032101222RXD-24Dispense Package Method
25..250-CEO*-01476RXD-25Supplementary CodeNEW
26..250-CEO1-01477RXD-26Initiating LocationNEW
27..250-CEO1-01478RXD-27Packaging/Assembly LocationNEW
6